LifeStance Health (LFST) Revenue (2020 - 2026)

LifeStance Health (LFST) has reported Revenue for 7 consecutive years, with $403.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue rose 21.17% year-over-year to $403.5 million; the TTM figure through Mar 2026 stood at $1.5 billion (up 16.46% YoY), while the FY2025 annual figure was $1.4 billion, up 13.85% from the prior year.
• Revenue advanced to $403.5 million in Q1 2026 per LFST's latest filing, from $382.2 million in the prior quarter.
• Across five years, Revenue topped out at $403.5 million in Q1 2026 and bottomed at $203.1 million in Q1 2022.
• Historically, Revenue has averaged $293.8 million across 5 years, with a median of $300.4 million in 2024.
• Annual changes were most pronounced in 2022 — Revenue soared 41.89% — and 2025, when it rose 10.56%.
• LifeStance Health's Revenue stood at $229.4 million in 2022, then grew by 22.34% to $280.6 million in 2023, then gained by 15.99% to $325.5 million in 2024, then grew by 17.43% to $382.2 million in 2025, then grew by 5.57% to $403.5 million in 2026.
• Business Quant data shows LFST's Revenue at $403.5 million in Q1 2026, $382.2 million in Q4 2025, and $363.8 million in Q3 2025.